Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
1.
J Ethnopharmacol ; 323: 117616, 2024 Apr 06.
Article in English | MEDLINE | ID: mdl-38142877

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Rice (Oryza sativa L.), a staple food for a significant portion of the global population, has been recognized for its traditional medicinal properties for centuries. Rice bran, a by-product of rice milling, contains many bioactive compounds with potential pharmaceutical and therapeutic benefits. In recent years, research has highlighted the anti-inflammatory potential of rice bran, contributed by the bioactive components concentrated in their bran but, unfortunately, entrapped in the bran matrix, with limited bioavailability. Previous studies have reported that the enzymatic treatment of rice bran improves the bran's bioactive compound profile but did not investigate its impact on chronic conditions such as inflammation. AIM OF THE STUDY: This study investigates the anti-inflammatory effects of endo-1,4-ß-xylanase (ERB) and Viscozyme (VRB) treated red rice bran extracts against lipopolysaccharide-induced inflammation in RAW264.7 macrophages in comparison with non-enzyme-treated bran (CRB). Further established their efficacy with known anti-inflammatory compounds-ferulic acid (FA), catechin (CAT), γ-tocopherol (GTP), and γ-oryzanol (ORZ). MATERIALS AND METHODS: The RAW 264.7 macrophage cells were pre-treated with non-toxic concentrations (10-200 µg/mL) of FA, CAT, GTP, ORZ, CRB, ERB, and VRB, followed by inflammatory stimulation with LPS for 24 h. Further, the cell supernatant and pellets were harvested to study the anti-inflammatory effects by evaluating and measuring their efficacy in inhibiting pro-inflammatory cytokines (TNF-α, IL-6, IL-10, IL-1ß) and mediators (ROS, NO, PGE2, COX2, iNOS) through biochemical, ELISA, and mRNA expression studies. RESULTS: The findings showed that both ERB and VRB effectively inhibited the production of pro-inflammatory markers (TNF-α, IL-6) and mediators (ROS, NO, PGE2) by downregulating mRNA expressions of inflammatory genes (TNF-α, IL-1ß, IL-6, IL-10, COX2, iNOS) and demonstrated anti-inflammatory efficacy higher than CRB. On comparison, ERB demonstrated exceptional efficacy by causing a reduction of 48% in ROS, 20% in TNF-α, and 23% in PGE2 at 10 µg/mL, surpassing the anti-inflammatory capabilities of all the bioactive compounds, FA and ORZ, respectively. At the same time, VRB exhibited remarkable efficacy by reducing NO production by 52% at 200 µg/mL and IL-6 by 66% at 10 µg/mL, surpassing FA, CAT, ORZ, and GTP. Further, ERB downregulated the mRNA expression of IL-10 and iNOS, while VRB downregulated TNF-α, IL-1ß, and COX2 expression. Both extracts equally downregulated IL-6 expression at 10 µg/mL, demonstrating the efficacy more remarkable/on par with established anti-inflammatory compounds. CONCLUSIONS: Overall, enzyme-treated rice bran/extract, particularly ERB, possesses excellent anti-inflammatory properties, making them promising agents for alternatives to contemporary nutraceuticals/functional food against inflammatory diseases.


Subject(s)
Catechin , Coumaric Acids , Oryza , Phenylpropionates , Oryza/chemistry , gamma-Tocopherol/metabolism , gamma-Tocopherol/pharmacology , gamma-Tocopherol/therapeutic use , Interleukin-10/metabolism , Catechin/pharmacology , Tumor Necrosis Factor-alpha/metabolism , Interleukin-6/metabolism , Dinoprostone/metabolism , Cyclooxygenase 2/metabolism , Reactive Oxygen Species/metabolism , Anti-Inflammatory Agents/therapeutic use , Plant Extracts/therapeutic use , Inflammation/drug therapy , Inflammation/metabolism , Macrophages , RNA, Messenger/metabolism , Guanosine Triphosphate/metabolism , Guanosine Triphosphate/pharmacology , Guanosine Triphosphate/therapeutic use , Lipopolysaccharides/pharmacology
2.
Int J Mol Sci ; 22(17)2021 Aug 29.
Article in English | MEDLINE | ID: mdl-34502281

ABSTRACT

M. alba L. is a valuable nutraceutical plant rich in potential bioactive compounds with promising anti-gouty arthritis. Here, we have explored bioactives, signaling pathways, and key proteins underlying the anti-gout activity of M. alba L. leaves for the first-time utilizing network pharmacology. Bioactives in M. alba L. leaves were detected through GC-MS (Gas Chromatography-Mass Spectrum) analysis and filtered by Lipinski's rule. Target proteins connected to the filtered compounds and gout were selected from public databases. The overlapping target proteins between bioactives-interacted target proteins and gout-targeted proteins were identified using a Venn diagram. Bioactives-Proteins interactive networking for gout was analyzed to identify potential ligand-target and visualized the rich factor on the R package via the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway on STRING. Finally, a molecular docking test (MDT) between bioactives and target proteins was analyzed via AutoDock Vina. Gene Set Enrichment Analysis (GSEA) demonstrated that mechanisms of M. alba L. leaves against gout were connected to 17 signaling pathways on 26 compounds. AKT1 (AKT Serine/Threonine Kinase 1), γ-Tocopherol, and RAS signaling pathway were selected as a hub target, a key bioactive, and a hub signaling pathway, respectively. Furthermore, three main compounds (γ-Tocopherol, 4-Dehydroxy-N-(4,5-methylenedioxy-2-nitrobenzylidene) tyramine, and Lanosterol acetate) and three key target proteins-AKT1, PRKCA, and PLA2G2A associated with the RAS signaling pathway were noted for their highest affinity on MDT. The identified three key bioactives in M. alba L. leaves might contribute to recovering gouty condition by inactivating the RAS signaling pathway.


Subject(s)
Gout Suppressants/pharmacology , Morus/chemistry , Plant Leaves/chemistry , ras Proteins/metabolism , Animals , Drug Evaluation, Preclinical , Gas Chromatography-Mass Spectrometry , Gout/drug therapy , Gout/metabolism , Gout Suppressants/chemistry , Gout Suppressants/toxicity , Humans , Molecular Docking Simulation , Protein Interaction Maps , Signal Transduction/drug effects , gamma-Tocopherol/analysis , gamma-Tocopherol/pharmacology
3.
Clin Exp Immunol ; 206(2): 161-172, 2021 11.
Article in English | MEDLINE | ID: mdl-34331768

ABSTRACT

Gamma-tocotrienol (γT3) is an analogue of vitamin E with beneficial effects on the immune system, including immune-modulatory properties. This study reports the immune-modulatory effects of daily supplementation of γT3 on host T helper (Th) and T regulatory cell (Treg ) populations in a syngeneic mouse model of breast cancer. Female BALB/c mice were fed with either γT3 or vehicle (soy oil) for 2 weeks via oral gavage before they were inoculated with syngeneic 4T1 mouse mammary cancer cells (4T1 cells). Supplementation continued until the mice were euthanized. Mice (n = 6) were euthanized at specified time-points for various analysis (blood leucocyte, cytokine production and immunohistochemistry). Tumour volume was measured once every 7 days. Gene expression studies were carried out on tumour-specific T lymphocytes isolated from splenic cultures. Supplementation with γT3 increased CD4+ (p < 0.05), CD8+ (p < 0.05) T-cells and natural killer cells (p < 0.05) but suppressed Treg cells (p < 0.05) in peripheral blood when compared to animals fed with the vehicle. Higher interferon (IFN)-γ and lower transforming growth factor (TGF)-ꞵ levels were noted in the γT3 fed mice. Immunohistochemistry findings revealed higher infiltration of CD4+ cells, increased expression of interleukin-12 receptor-beta-2 (IL-12ꞵ2R), interleukin (IL)-24 and reduced expression of cells that express the forkhead box P3 (FoxP3) in tumours from the γT3-fed animals. Gene expression studies showed the down-regulation of seven prominent genes in splenic CD4+ T cells isolated from γT3-fed mice. Supplementation with γT3 from palm oil-induced T cell-dependent cell-mediated immune responses and suppressed T cells in the tumour microenvironment in a syngeneic mouse model of breast cancer.


Subject(s)
Dietary Supplements , Lymphocytes, Tumor-Infiltrating/immunology , Mammary Neoplasms, Animal/immunology , T-Lymphocytes, Regulatory/immunology , Tumor Microenvironment/drug effects , gamma-Tocopherol/pharmacology , Animals , Cell Line, Tumor , Cytokines/immunology , Female , Killer Cells, Natural/immunology , Mammary Neoplasms, Animal/drug therapy , Mice , Mice, Inbred BALB C , Neoplasm Proteins/immunology
4.
Nutrition ; 85: 111139, 2021 05.
Article in English | MEDLINE | ID: mdl-33549947

ABSTRACT

OBJECTIVES: The aim of this study was to evaluate the effect of the dietary supplementation of an alpha- and gamma-tocopherol mixture (1:5 ratio) in the adipose tissue expansion, hepatic steatosis, and expression of inflammatory markers induced by consumption of a high-fat diet (HFD) in mice. METHODS: Male C57BL/6 J mice were fed for 12 wk and divided into the following: 1) control diet (CD; 10% fat, 20% protein, 70% carbohydrates); 2) CD + TF (CD plus alpha-tocopherol: 0.7 mg/kg/d, gamma-tocopherol: 3.5 mg/kg/d); 3) HFD (60% fat, 20% protein, 20% carbohydrates); and 4) HFD + TF (HFD plus alpha-tocopherol: 0.7 mg/kg/d, gamma-tocopherol: 3.5 mg/kg/d). General parameters, adipocyte size, liver steatosis, adipose and hepatic tumor necrosis factor-α (TNF-α) and interleukin-1 ß (IL-1ß) expression, hepatic nuclear factor kappa B (NF-κB), and peroxisome proliferator-activated receptor α (PPAR-α) levels were evaluated. RESULTS: Tocopherol supplementation in HFD-fed mice showed a significant decrease in the body weight (19%) and adipose tissue weight (52%), adipose tissue/body weight ratio (36%), and serum triacylglycerols (56%); a 42% decrease (P < 0.05) of adipocyte size compared to HFD; attenuation of liver steatosis by decreasing (P < 0.05) lipid vesicles presence (90%) and total lipid content (75%); and downregulation of inflammatory markers (TNF-α and IL-1ß), along with an upregulation of hepatic PPAR-α expression and its downstream-regulated genes (ACOX and CAT-1), and an inhibition of hepatic NF-κB activation. CONCLUSION: The present study suggests that alpha- and gamma-tocopherol (1:5 ratio) supplementation attenuates the adipocyte enlargement, hepatic steatosis, and metabolic inflammation induced by HFD in association with PPAR-α/NF-κB modulation.


Subject(s)
Diet, High-Fat , Fatty Liver , Adipose Tissue , Animals , Diet, High-Fat/adverse effects , Dietary Supplements , Disease Models, Animal , Fatty Liver/etiology , Fatty Liver/prevention & control , Liver , Male , Mice , Mice, Inbred C57BL , Tissue Expansion , gamma-Tocopherol/pharmacology
5.
Curr Drug Discov Technol ; 18(2): 317-332, 2021.
Article in English | MEDLINE | ID: mdl-32208118

ABSTRACT

AIMS AND OBJECTIVE: In this study, a novel quantitative structure activity relationship (QSAR) model has been developed for inhibitors of human 5-alpha reductase type II, which are used to treat benign prostate hypertrophy (BPH). METHODS: The dataset consisted of 113 compounds-mainly nonsteroidal-with known inhibitory concentration. Then 3D structures of compounds were optimized and molecular structure descriptors were calculated. The stepwise multiple linear regression was used to select descriptors encoding the inhibitory activity of the compounds. Multiple linear regression (MLR) was used to build up the linear QSAR model. RESULTS: The results obtained revealed that the descriptors which best describe the activity were atom type electropological state, carbon type, radial distribution function (RDF), barysz matrix and molecular linear free energy relation. The suggested model could achieve satisfied square correlation coefficient of R2 = 0.72, higher than of many previous studies, indicating its superiority. Rigid validation criteria were met using external data with Q2 ˃ 0.5 and R2 = 0.75, reflecting the predictive power of the model. CONCLUSION: The QSAR model was applied for screening botanical components of herbal preparations used to treat BPH, and could predict the activity of some, among others, making reasonable attribution to the proposed effect of these preparations. Gamma tocopherol was found to be an active inhibitor, in consistence with many previous studies, anticipating the power of this model in the prediction of new candidate molecules and suggesting further investigations.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase , 5-alpha Reductase Inhibitors/pharmacology , Membrane Proteins , Prostatic Hyperplasia , Quantitative Structure-Activity Relationship , gamma-Tocopherol/pharmacology , 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/metabolism , Dihydrotestosterone/metabolism , Drug Discovery , Humans , Isoenzymes , Male , Membrane Proteins/antagonists & inhibitors , Membrane Proteins/metabolism , Plant Preparations/pharmacology , Prostatic Hyperplasia/drug therapy , Prostatic Hyperplasia/metabolism
6.
Nutrition ; 53: 1-8, 2018 09.
Article in English | MEDLINE | ID: mdl-29625348

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate the contribution of tocopherols present in Rosa mosqueta oil (RM) in the prevention of high-fat diet (HFD)-induced alterations. METHODS: Male C57 BL/6 J mice (n = 9/group) were fed for 12 wk and divided into four groups: control (CD; 10% kcal fat, 20% kcal protein, 70% kcal carbohydrates); HFD (60% as fat, 20% kcal protein, 20% kcal carbohydrates); HFD + RM (0.01 mL/g body weight/d); and HFD + RM- without tocopherols (0.01 mL/g body weight/d). Parameters of obesity, liver steatosis (histology, triacylglycerols content), inflammation (adipose NLRP3 inflammasome, tumor necrosis factor-α and interleukin-1 ß expression, hepatic nuclear factor-κB) and oxidative stress (hepatic Nrf2 activation, carbonylated proteins) were evaluated. RESULTS: Liver steatosis, inflammatory, and oxidative stress parameters were significantly (P < 0.05) increased in the HFD + RM- compared with the HFD + RM, with no differences between HFD and HFD + RM-. CONCLUSION: The present study suggests that α- and γ-tocopherols from RM may have an important role in the prevention of alterations induced by HFD.


Subject(s)
Diet, High-Fat/adverse effects , Inflammation/prevention & control , Oxidative Stress/drug effects , Plant Oils/pharmacology , Rosa , alpha-Tocopherol/pharmacology , gamma-Tocopherol/pharmacology , Animals , Disease Models, Animal , Fatty Liver/prevention & control , Male , Mice , Mice, Inbred C57BL
7.
J Allergy Clin Immunol ; 141(4): 1231-1238.e1, 2018 04.
Article in English | MEDLINE | ID: mdl-28736267

ABSTRACT

BACKGROUND: We and others have shown that the gamma tocopherol (γT) isoform of vitamin E has multiple anti-inflammatory and antioxidant actions and that γT supplementation reduces eosinophilic and endotoxin (LPS)-induced neutrophilic airway inflammation in animal models and healthy human volunteers. OBJECTIVE: We sought to determine whether γT supplementation reduces eosinophilic airway inflammation and acute neutrophilic response to inhaled LPS challenge in volunteers with asthma. METHODS: Participants with mild asthma were enrolled in a double-blinded, placebo-controlled crossover study to assess the effect of 1200 mg of γT daily for 14 days on sputum eosinophils, mucins, and cytokines. We also assessed the effect on acute inflammatory response to inhaled LPS challenge following γT treatment, focusing on changes in sputum neutrophilia, mucins, and cytokines. Mucociliary clearance was measured using gamma scintigraphy. RESULTS: Fifteen subjects with mild asthma completed both arms of the study. Compared with placebo, γT notably reduced pre-LPS challenge sputum eosinophils and mucins, including mucin 5AC and reduced LPS-induced airway neutrophil recruitment 6 and 24 hours after challenge. Mucociliary clearance was slowed 4 hours postchallenge in the placebo group but not in the γT treatment group. Total sputum mucins (but not mucin 5AC) were reduced at 24 hours postchallenge during γT treatment compared with placebo. CONCLUSIONS: When compared with placebo, γT supplementation for 14 days reduced inflammatory features of asthma, including sputum eosinophils and mucins, as well as acute airway response to inhaled LPS challenge. Larger scale clinical trials are needed to assess the efficacy of γT supplements as a complementary or steroid-sparing treatment for asthma.


Subject(s)
Asthma/drug therapy , Endotoxins/adverse effects , Eosinophilia/drug therapy , Eosinophils/drug effects , Neutrophil Infiltration/drug effects , Vitamins/therapeutic use , gamma-Tocopherol/therapeutic use , Adult , Asthma/immunology , Asthma/metabolism , Biomarkers/metabolism , Cross-Over Studies , Double-Blind Method , Drug Administration Schedule , Endotoxins/administration & dosage , Endotoxins/immunology , Eosinophilia/metabolism , Eosinophils/metabolism , Female , Humans , Male , Middle Aged , Mucins/metabolism , Sputum/drug effects , Sputum/metabolism , Treatment Outcome , Vitamins/pharmacology , gamma-Tocopherol/pharmacology
8.
Adv Nutr ; 8(6): 850-867, 2017 Nov.
Article in English | MEDLINE | ID: mdl-29141970

ABSTRACT

Initial research on vitamin E and cancer has focused on α-tocopherol (αT), but recent clinical studies on cancer-preventive effects of αT supplementation have shown disappointing results, which has led to doubts about the role of vitamin E, including different vitamin E forms, in cancer prevention. However, accumulating mechanistic and preclinical animal studies show that other forms of vitamin E, such as γ-tocopherol (γT), δ-tocopherol (δT), γ-tocotrienol (γTE), and δ-tocotrienol (δTE), have far superior cancer-preventive activities than does αT. These vitamin E forms are much stronger than αT in inhibiting multiple cancer-promoting pathways, including cyclo-oxygenase (COX)- and 5-lipoxygenase (5-LOX)-catalyzed eicosanoids, and transcription factors such as nuclear transcription factor κB (NF-κB) and signal transducer and activator of transcription factor 3 (STAT3). These vitamin E forms, but not αT, cause pro-death or antiproliferation effects in cancer cells via modulating various signaling pathways, including sphingolipid metabolism. Unlike αT, these vitamin E forms are quickly metabolized to various carboxychromanols including 13'-carboxychromanols, which have even stronger anti-inflammatory and anticancer effects than some vitamin precursors. Consistent with mechanistic findings, γT, δT, γTE, and δTE, but not αT, have been shown to be effective for preventing the progression of various types of cancer in preclinical animal models. This review focuses on cancer-preventive effects and mechanisms of γT, δT, γTE, and δTE in cells and preclinical models and discusses current progress in clinical trials. The existing evidence strongly indicates that these lesser-known vitamin E forms are effective agents for cancer prevention or as adjuvants for improving prevention, therapy, and control of cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinogenesis/drug effects , Neoplasms/prevention & control , Vitamin E/pharmacology , Vitamins/pharmacology , Animals , Chromans/pharmacology , Humans , Neoplasms/therapy , Signal Transduction/drug effects , Tocopherols/pharmacology , Vitamin E/analogs & derivatives , gamma-Tocopherol/pharmacology
9.
Nutrients ; 9(6)2017 Jun 13.
Article in English | MEDLINE | ID: mdl-28629117

ABSTRACT

Antioxidants have a number of potential health benefits. The present investigation was designed to determine the relationship between serum alpha- and gamma-tocopherol levels (powerful antioxidants), and leukocyte telomere length (a biomarker of biological aging). A cross-sectional design was employed to study 5768 adults from the National Health and Nutrition Examination Survey (NHANES). DNA was obtained via blood samples. Telomere length was assessed using the quantitative polymerase chain reaction method. Serum concentrations of alpha- and gamma-tocopherol were measured using high performance liquid chromatography (HPLC). Results showed that for each one-year increase in age, telomeres were 15.6 base pairs shorter (F = 410.4, p < 0.0001). After adjusting for differences in the demographic covariates, for each µg/dL higher level of gamma-tocopherol, telomeres were 0.33 base pairs shorter (F = 7.1, p = 0.0126). Telomeres were approximately 1 year shorter (15.6 base pairs) for each increment of 47.3 to 55.7 µg/dL of gamma-tocopherol in the blood, depending on the variables controlled. Adults at the 75th percentile of gamma-tocopherol had 2.8-3.4 years greater cellular aging than those at the 25th percentile, depending on the covariates in the model. However, alpha-tocopherol was not related to telomere length. Evidently, gamma-tocopherol levels, but not alpha-tocopherol, account for meaningful increases in biological aging.


Subject(s)
Telomere Homeostasis/drug effects , alpha-Tocopherol/blood , gamma-Tocopherol/blood , Cross-Sectional Studies , DNA , Diet , Dietary Supplements , Female , Food Analysis , Humans , Leukocytes/cytology , Male , Middle Aged , Nutrition Surveys , Oxidative Stress , United States , Vitamin E/administration & dosage , alpha-Tocopherol/pharmacology , gamma-Tocopherol/pharmacology
11.
Am J Ther ; 24(6): e706-e712, 2017.
Article in English | MEDLINE | ID: mdl-27058575

ABSTRACT

In this work, we characterized by high-performance liquid chromatography, the γ-tocopherol (573.66 µg/g), and by gas chromatography-mass spectrometry, the linoleic acid (62.05%) as major components from Peganum harmala L. seeds oil and evaluated their potential in vivo acute antiinflammatory, analgesic activities, and in vitro antioxidative capacity. The 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay showed an important antioxidant activity (62.50% with an IC50 of 4.8 mg/mL). In addition, the antiinflammatory effect of the formulation cream at 20% caused a reduction in inflammation at 5 hours after carrageenan application compared with diclofenac at 1% (60.4%; 45.65%; respectively). A slight potential peripheral analgesia was noted in plantar test in treated rats with cream (20 s). Therefore, our findings demonstrate that formulation cream of P. harmala seeds oil has an interesting antiinflammatory activity with a slight peripheral analgesic effect due mainly to its richness on linoleic acid, γ-tocopherol, and polyphenols and to its important antioxidant capacity.


Subject(s)
Dermatitis, Atopic/drug therapy , Peganum/chemistry , Plant Extracts/pharmacology , Plant Oils/chemistry , Seeds/chemistry , Analgesics/pharmacology , Analgesics/therapeutic use , Animals , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Antioxidants/pharmacology , Antioxidants/therapeutic use , Carrageenan/toxicity , Chromatography, High Pressure Liquid/methods , Dermatitis, Atopic/chemically induced , Disease Models, Animal , Gas Chromatography-Mass Spectrometry/methods , Humans , Linoleic Acid/pharmacology , Male , Plant Extracts/therapeutic use , Rats , Rats, Wistar , Skin Cream/pharmacology , gamma-Tocopherol/pharmacology
12.
Int J Mol Sci ; 17(12)2016 Nov 25.
Article in English | MEDLINE | ID: mdl-27897980

ABSTRACT

Lipid peroxidation products, such as 7-ketocholesterol (7KC), may be increased in the body fluids and tissues of patients with neurodegenerative diseases and trigger microglial dysfunction involved in neurodegeneration. It is therefore important to identify synthetic and natural molecules able to impair the toxic effects of 7KC. We determined the impact of 7KC on murine microglial BV-2 cells, especially its ability to trigger mitochondrial and peroxisomal dysfunction, and evaluated the protective effects of α- and γ-tocopherol, Trolox, and oleic acid (OA). Multiple complementary chemical assays, flow cytometric and biochemical methods were used to evaluate the antioxidant and cytoprotective properties of these molecules. According to various complementary assays to estimate antioxidant activity, only α-, and γ-tocopherol, and Trolox had antioxidant properties. However, only α-tocopherol, γ-tocopherol and OA were able to impair 7KC-induced loss of mitochondrial transmembrane potential, which is associated with increased permeability to propidium iodide, an indicator of cell death. In addition, α-and γ-tocopherol, and OA were able to prevent the decrease in Abcd3 protein levels, which allows the measurement of peroxisomal mass, and in mRNA levels of Abcd1 and Abcd2, which encode for two transporters involved in peroxisomal ß-oxidation. Thus, 7KC-induced side effects are associated with mitochondrial and peroxisomal dysfunction which can be inversed by natural compounds, thus supporting the hypothesis that the composition of the diet can act on the function of organelles involved in neurodegenerative diseases.


Subject(s)
Ketocholesterols/pharmacology , Microglia/drug effects , Microglia/metabolism , Mitochondria/drug effects , Oleic Acid/pharmacology , Olive Oil/pharmacology , Peroxisomes/drug effects , alpha-Tocopherol/pharmacology , gamma-Tocopherol/pharmacology , Animals , Antioxidants/pharmacology , Cell Line , Membrane Potential, Mitochondrial/drug effects , Mice , Mitochondria/pathology , Peroxisomes/pathology
13.
Eur J Clin Nutr ; 69(8): 867-73, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25669317

ABSTRACT

C-reactive protein (CRP), a marker of chronic inflammation, has a major role in the etiology of chronic disease. Vitamin E may have anti-inflammatory effects. However, there is no consensus on the effects of vitamin E supplementation on CRP levels in clinical trials. The aim of this study was to systematically review randomized controlled trials (RCTs) that report on the effects of vitamin E supplementation (α- and γ-tocopherols) on CRP levels. A systematic search of RCTs was conducted on Medline and EMBASE through PubMed, Scopus, Ovid and Science Direct, and completed by a manual review of the literature up to May 2014. Pooled effects were estimated by using random-effects models and heterogeneity was assessed by Cochran's Q and I(2) tests. Subgroup analyses and meta-regression analyses were also performed according to intervention duration, dose of supplementation and baseline level of CRP. Of 4734 potentially relevant studies, only 12 trials met the inclusion criteria with 246 participants in the intervention arms and 249 participants in control arms. Pooled analysis showed a significant reduction in CRP levels of 0.62 mg/l (95% confidence interval = -0.92, -0.31; P < 0.001) in vitamin E-treated individuals, with the evidence of heterogeneity across studies. This significant effect was maintained in all subgroups, although the univariate meta-regression analysis showed that the vitamin E supplementation dose, baseline level of CRP and duration of intervention were not the sources of the observed heterogeneity. The results of this meta-analysis suggest that supplementation with vitamin E in the form of either α-tocopherol or γ-tocopherol would reduce serum CRP levels.


Subject(s)
C-Reactive Protein/metabolism , Dietary Supplements , Vitamins/pharmacology , alpha-Tocopherol/pharmacology , gamma-Tocopherol/pharmacology , Anti-Inflammatory Agents/pharmacology , Biomarkers/blood , Humans , Inflammation/drug therapy , Randomized Controlled Trials as Topic
14.
J Sci Food Agric ; 95(13): 2571-8, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25472416

ABSTRACT

Although sesame seed oil contains high levels of unsaturated fatty acids and even a small amount of free fatty acids in its unrefined flavored form, it shows markedly greater stability than other dietary vegetable oils. The good stability of sesame seed oil against autoxidation has been ascribed not only to its inherent lignans and tocopherols but also to browning reaction products generated when sesame seeds are roasted. Also, there is a strong synergistic effect among these components. The lignans in sesame seed oil can be categorized into two types, i.e. inherent lignans (sesamin, sesamolin) and lignans mainly formed during the oil production process (sesamol, sesamolinol, etc.). The most abundant tocopherol in sesame seed oil is γ-tocopherol. This article reviews the antioxidant activities of lignans and tocopherols as well as the browning reaction and its products in sesame seed and/or its oil. It is concluded that the composition and structure of browning reaction products and their impacts on sesame ingredients need to be further studied to better explain the remaining mysteries of sesame oil.


Subject(s)
Antioxidants/pharmacology , Benzodioxoles/pharmacology , Dioxoles/pharmacology , Lignans/pharmacology , Phenols/pharmacology , Seeds/chemistry , Sesame Oil/chemistry , Sesamum/chemistry , gamma-Tocopherol/pharmacology , Antioxidants/analysis , Benzodioxoles/analysis , Diet , Dioxoles/analysis , Humans , Lignans/analysis , Phenols/analysis , gamma-Tocopherol/analysis
15.
Int J Food Microbiol ; 189: 1-10, 2014 Oct 17.
Article in English | MEDLINE | ID: mdl-25108759

ABSTRACT

Buckwheat (Fagopyrum spp.) is a "pseudo-cereal" of great interest in the production of healthy foods since its flour, derived from achenes, is enriched with bioactive compounds and, due to the absence of gluten, may be used in composition of celiac diets. Amongst buckwheat species, F. tataricum achenes possess a larger amount of the antioxidant flavenol rutin than the common buckwheat F. esculentum. Ongoing climate change may favor plant susceptibility to the attack by pathogenic, often mycotoxigenic, fungi with consequent increase of mycotoxins in previously unexploited feeds and foodstuffs. In particular, Aspergillus flavus, under suitable environmental conditions such as those currently occurring in Italy, may produce aflatoxin B1 (AFB1), the most carcinogenic compound of fungal origin which is classified by IARC as Category 1. In this study, the viable achenes of two buckwheat species, F. tataricum (var. Golden) and F. esculentum (var. Aelita) were inoculated with an AFB1-producing A. flavus NRRL 3357 to analyze their relative performances against fungal invasion and toxin contamination. Notably, we sought the existence of a correlation between the amount of tocols/flavonols in the achenes of buckwheat, infected and non-infected with A. flavus, and to analyze the ability of the pathogen to grow and produce toxin during achene infection. Results suggest that achenes of F. tataricum, the best producer of antioxidant compounds in this study, are less susceptible to A. flavus infection and consequently, but not proportionally, to mycotoxin contamination compared with F. esculentum. Moreover, rutin-derived quercetin appears to be more efficient in inhibiting aflatoxin biosynthesis than the parent compound.


Subject(s)
Aflatoxin B1/antagonists & inhibitors , Antioxidants/pharmacology , Aspergillus flavus/drug effects , Fagopyrum/metabolism , Plant Diseases/microbiology , Seeds/metabolism , Aflatoxin B1/biosynthesis , Antioxidants/isolation & purification , Antioxidants/metabolism , Aspergillus flavus/growth & development , Fagopyrum/microbiology , Italy , Plant Extracts/chemistry , Quercetin/biosynthesis , Quercetin/isolation & purification , Quercetin/pharmacology , Rutin/biosynthesis , Rutin/isolation & purification , Rutin/pharmacology , Seeds/microbiology , gamma-Tocopherol/isolation & purification , gamma-Tocopherol/metabolism , gamma-Tocopherol/pharmacology
16.
Allergy ; 69(4): 541-4, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24697338

ABSTRACT

Epidemiologic studies suggest that dietary vitamin E is a candidate intervention for atopic disease. We used in vitro and ex vivo exposures to test the hypothesis that the most common dietary isoform of vitamin E, γ-tocopherol (γT), could suppress FcεRI-mediated basophil activation. Rat basophilic leukemia (RBL)-SX38 cells that express human FcεRI were treated with or without γT, followed by stimulation with α-IgE. In the ex vivo study, 20 Der f 1-allergic volunteers consumed a γT-enriched supplement for 7 days. Their basophils were challenged ex vivo with α-IgE and graded doses of Der f 1 before and after the supplementation period. γt treatment of RBL-SX38 cells significantly reduced basophil degranulation and de novo TH2 cytokine production. Daily consumption of a γT-rich supplement by dust mite-allergic volunteers reduced basophil activation after ex vivo dust mite challenge. Vitamin E supplements rich in γT may be useful adjuncts in decreasing atopic disease.


Subject(s)
Antigens, Dermatophagoides/immunology , Basophils/drug effects , Basophils/immunology , Vitamin E/pharmacology , gamma-Tocopherol/pharmacology , Cell Degranulation/drug effects , Cell Degranulation/immunology , Cell Line , Cytokines/biosynthesis , Humans , Immunoglobulin E/immunology , Leukotriene D4/metabolism
17.
Nutrients ; 5(11): 4347-63, 2013 Oct 31.
Article in English | MEDLINE | ID: mdl-24184873

ABSTRACT

Asthma and allergic diseases are complex conditions caused by a combination of genetic and environmental factors. Clinical studies suggest a number of protective dietary factors for asthma, including vitamin E. However, studies of vitamin E in allergy commonly result in seemingly conflicting outcomes. Recent work indicates that allergic inflammation is inhibited by supplementation with the purified natural vitamin E isoform α-tocopherol but elevated by the isoform γ-tocopherol when administered at physiological tissue concentrations. In this review, we discuss opposing regulatory effects of α-tocopherol and γ-tocopherol on allergic lung inflammation in clinical trials and in animal studies. A better understanding of the differential regulation of inflammation by isoforms of vitamin E provides a basis towards the design of clinical studies and diets that would effectively modulate inflammatory pathways in lung disease.


Subject(s)
Asthma , Immunologic Factors/pharmacology , Inflammation , Lung/drug effects , Pneumonia , alpha-Tocopherol/pharmacology , gamma-Tocopherol/pharmacology , Animals , Antioxidants/adverse effects , Antioxidants/pharmacology , Antioxidants/therapeutic use , Asthma/etiology , Asthma/prevention & control , Diet , Dietary Supplements , Humans , Immunologic Factors/adverse effects , Immunologic Factors/therapeutic use , Inflammation/etiology , Inflammation/prevention & control , Pneumonia/etiology , Pneumonia/prevention & control , Protein Isoforms , alpha-Tocopherol/therapeutic use , gamma-Tocopherol/adverse effects
18.
Arch Biochem Biophys ; 538(2): 111-9, 2013 Oct 15.
Article in English | MEDLINE | ID: mdl-23993952

ABSTRACT

Of the 8 different analogues (α-, ß-, γ-, δ-tocopherols and tocotrienols) designated as vitamin E, alpha-tocopherol (α-T) has been mostly studied, together with gamma-tocopherol (γ-T) which is abundant in the US diet. We compared the effect of dietary supplementation with adequate or high doses of α-T or γ-T on the number and type of genes expressed following T cell activation. C57BL/6 mice were fed diets containing adequate (30 ppm) or high (500 ppm) amounts of α-T or γ-T for 4 weeks. Spleen T cells were stimulated ex vivo with plate-bound anti-CD3 and soluble anti-CD28, and gene expression changes were assessed by gene array analysis. The data obtained indicated significant qualitative and quantitative differences between the two analogs in regulating gene expression induced by T cell stimulation. Genes were found uniquely responding to either high α-T (e.g. induced: CD40 ligand, lymphotoxin A) or γ-T (e.g. repressed: poliovirus receptor-related-2). Interestingly, in stimulated T-cells from mice supplemented with high amounts of α-T a bigger number of genes were activated than in mice supplemented with the same amounts of γ-T; under the same conditions γ-T repressed the expression of a number of genes larger than α-T. It is possible that the observed diminution in gene expression in T cells after high γ-T in vivo supplementation modulates inflammation or other T cell mediated functions.


Subject(s)
Antioxidants/pharmacology , Gene Expression Regulation/drug effects , T-Lymphocytes/drug effects , Vitamins/pharmacology , alpha-Tocopherol/pharmacology , gamma-Tocopherol/pharmacology , Animals , Antioxidants/administration & dosage , Cells, Cultured , Dietary Supplements , Gene Ontology , Male , Mice , Mice, Inbred C57BL , T-Lymphocytes/metabolism , Transcriptional Activation/drug effects , Vitamins/administration & dosage , alpha-Tocopherol/administration & dosage , gamma-Tocopherol/administration & dosage
19.
Free Radic Biol Med ; 65: 1069-1077, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24013093

ABSTRACT

Inflammation can promote colon cancer. Mechanistic studies indicate that γ-tocopherol (γT), a major form of vitamin E in diets, has anti-inflammatory and anticancer properties. Here we investigated the effectiveness of γT and a mixture of tocopherols against colitis and colitis-promoted colon tumorigenesis in male BALB/c mice. γT or mixed tocopherols (at 0.1% diet) did not show any effect on colon tumorigenesis induced by azoxymethane (AOM, 10mg/kg) with three cycles of dextran sodium sulfate (DSS at 1.5-2.5%). γT failed to exhibit protection of severe colitis caused by three cycles of DSS at 2.5%. In contrast, when AOM-initiated carcinogenesis was promoted by relatively mild colitis induced by one-cycle DSS (1.5%), γT, but not mixed tocopherols, suppressed total multiplicity of macroscopic adenomas (P=0.06) and large adenomatous polyps (>2mm(2), P<0.05) by 60 and 85%, respectively. γT also significantly decreased tumor multiplicity (>2mm(2)) induced by AOM with two cycles of 1.5% DSS even when dietary supplementation was started after AOM injection. Consistently, γT but not mixed tocopherols attenuated DSS (1.5%)-induced colon inflammation and damage as well as formation of atypical glandular hyperplasia. Mice supplemented with tocopherols had high fecal excretion of 13'-carboxychromanol, a long-chain vitamin E metabolite shown to have potent anti-inflammatory activities. Our study demonstrates that γT is able to alleviate moderate but not severe colitis and its promoted tumorigenesis, and indicates that inflammation severity should be considered in evaluating anticancer effectiveness of chemoprevention agents.


Subject(s)
Anticarcinogenic Agents/pharmacology , Carcinogenesis/drug effects , Colitis/drug therapy , Colonic Neoplasms/prevention & control , gamma-Tocopherol/pharmacology , Animals , Anticarcinogenic Agents/pharmacokinetics , Antioxidants/pharmacokinetics , Antioxidants/pharmacology , Colitis/chemically induced , Colitis/pathology , Colonic Neoplasms/chemically induced , Colonic Neoplasms/immunology , Dextran Sulfate , Disease Progression , Male , Mice, Inbred BALB C , gamma-Tocopherol/pharmacokinetics
20.
J Innate Immun ; 5(6): 613-24, 2013.
Article in English | MEDLINE | ID: mdl-23689260

ABSTRACT

Elevated inflammation and altered immune responses are features found in atopic asthmatic airways. Recent studies indicate γ-tocopherol (GT) supplementation can suppress airway inflammation in allergic asthma. We studied the effects of in vitro GT supplementation on receptor-mediated phagocytosis and expression of cell surface molecules associated with innate and adaptive immunity on sputum-derived macrophages. Cells from nonsmoking healthy (n = 6) and mild house dust mite-sensitive allergic asthmatics (n = 6) were treated ex vivo with GT (300 µM) or saline (control). Phagocytosis of opsonized zymosan A bioparticles (Saccharomyces cerevisiae) and expression of surface molecules associated with innate and adaptive immunity were assessed using flow cytometry. GT caused significantly decreased (p < 0.05) internalization of attached zymosan bioparticles and decreased (p < 0.05) macrophage expression of CD206, CD36 and CD86 in allergic asthmatics but not in controls. Overall, GT caused downregulation of both innate and adaptive immune response elements, and atopic status appears to be an important factor.


Subject(s)
Asthma/immunology , Macrophages/drug effects , Macrophages/immunology , gamma-Tocopherol/pharmacology , Adult , Animals , Asthma/pathology , B7-2 Antigen/immunology , B7-2 Antigen/metabolism , CD36 Antigens/immunology , CD36 Antigens/metabolism , Cell Survival/drug effects , Cell Survival/immunology , Cells, Cultured , Female , Flow Cytometry , Humans , Lectins, C-Type/immunology , Lectins, C-Type/metabolism , Macrophages/metabolism , Male , Mannose Receptor , Mannose-Binding Lectins/immunology , Mannose-Binding Lectins/metabolism , Phagocytosis/drug effects , Phagocytosis/immunology , Pyroglyphidae/immunology , Receptors, Cell Surface/immunology , Receptors, Cell Surface/metabolism , Sputum/cytology , Sputum/immunology , Vitamins/pharmacology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL